These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29350348)

  • 1. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.
    Perelló J; Gómez M; Ferrer MD; Rodríguez NY; Salcedo C; Buades JM; Pérez MM; Torregrosa JV; Martín E; Maduell F
    J Nephrol; 2018 Apr; 31(2):287-296. PubMed ID: 29350348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.
    Perelló J; Joubert PH; Ferrer MD; Canals AZ; Sinha S; Salcedo C
    Br J Clin Pharmacol; 2018 Dec; 84(12):2867-2876. PubMed ID: 30280390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
    Raggi P; Bellasi A; Bushinsky D; Bover J; Rodriguez M; Ketteler M; Sinha S; Salcedo C; Gillotti K; Padgett C; Garg R; Gold A; Perelló J; Chertow GM
    Circulation; 2020 Mar; 141(9):728-739. PubMed ID: 31707860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel assay to measure calcification propensity: from laboratory to humans.
    Perez MM; Ferrer MD; Lazo-Rodriguez M; Canals AZ; Banon-Maneus E; Campistol JM; Miller S; Garg R; Gold A; Salcedo C; Perelló J
    Sci Rep; 2020 Oct; 10(1):17578. PubMed ID: 33067536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.
    Perelló J; Ferrer MD; Del Mar Pérez M; Kaesler N; Brandenburg VM; Behets GJ; D'Haese PC; Garg R; Isern B; Gold A; Wolf M; Salcedo C
    Br J Pharmacol; 2020 Oct; 177(19):4400-4415. PubMed ID: 32557649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification.
    Zabirnyk A; Ferrer MD; Bogdanova M; Pérez MM; Salcedo C; Kaljusto ML; Kvitting JP; Stensløkken KO; Perelló J; Vaage J
    Vascul Pharmacol; 2019; 122-123():106583. PubMed ID: 31437530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.
    Bushinsky DA; Raggi P; Bover J; Ketteler M; Bellasi A; Rodriguez M; Sinha S; Garg R; Perelló J; Gold A; Chertow GM; ;
    Clin J Am Soc Nephrol; 2021 May; 16(5):736-745. PubMed ID: 33835939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: Phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification.
    Joubert P; Ketteler M; Salcedo C; Perello J
    Med Hypotheses; 2016 Sep; 94():89-92. PubMed ID: 27515210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis.
    Yang C; Wei Z; Shi W; Xing J; Zhang X
    J Nephrol; 2024 May; 37(4):851-863. PubMed ID: 38512376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.
    Brandenburg VM; Sinha S; Torregrosa JV; Garg R; Miller S; Canals AZ; Bahr D; Joubert PH; Salcedo C; Carroll KJ; Gold A; Perelló J
    J Nephrol; 2019 Oct; 32(5):811-821. PubMed ID: 31401795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNF472: mechanism of action and results from clinical trials.
    Sinha S; Raggi P; Chertow GM
    Curr Opin Nephrol Hypertens; 2021 Jul; 30(4):424-429. PubMed ID: 34027904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover Trial.
    Mineshima M; Takahashi S; Tomo T; Kawanishi H; Kawaguchi H; Minakuchi J; Nakanishi T; Sato T; Nitta K; Tsuchiya K; Masakane I; Itami N
    Blood Purif; 2019; 48(4):368-381. PubMed ID: 31311018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial.
    Raggi P; Bellasi A; Sinha S; Bover J; Rodriguez M; Ketteler M; Bushinsky DA; Garg R; Perelló J; Gold A; Chertow GM
    Kidney Int Rep; 2020 Dec; 5(12):2178-2182. PubMed ID: 33305110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.
    Ferrer MD; Ketteler M; Tur F; Tur E; Isern B; Salcedo C; Joubert PH; Behets GJ; Neven E; D'Haese PC; Perelló J
    PLoS One; 2018; 13(5):e0197061. PubMed ID: 29742152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
    Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
    Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification.
    Villa-Bellosta R; Hernández-Martínez E; Mérida-Herrero E; González-Parra E
    Sci Rep; 2019 Aug; 9(1):11374. PubMed ID: 31388059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.
    Ferrer MD; Pérez MM; Cànaves MM; Buades JM; Salcedo C; Perelló J
    Sci Rep; 2017 Jul; 7(1):6858. PubMed ID: 28761091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.
    Salcedo C; Joubert PH; Ferrer MD; Canals AZ; Maduell F; Torregrosa V; Campistol JM; Ojeda R; Perelló J
    Br J Clin Pharmacol; 2019 Apr; 85(4):796-806. PubMed ID: 30632182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First impressions of cardiovascular calcification treatment in hemodialysis patients with a new dialysis fluid containing sodium thiosulphate (STS).
    Yonova DH; Vazelov ES; Trendafilov II; Stoinova VV; Nedevska MT; Antonov SA
    Int J Artif Organs; 2014 Apr; 37(4):308-14. PubMed ID: 24811185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.
    Maduell F; Rodas L; Broseta JJ; Gómez M; Xipell Font M; Molina A; Montagud-Marrahi E; Guillén E; Arias-Guillén M; Fontseré N; Vera Rivera M; Rico N
    Artif Organs; 2019 Oct; 43(10):1014-1021. PubMed ID: 31038748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.